Iterum Therapeutics ITRMF
ITRMF
$0.00 +0.00 (+0.00%)
At close: Aug 19, 2026 · 4:00 PM EDT

Iterum Therapeutics plc (ITRMF) Times Interest Earned (2017 - 2025)

Iterum Therapeutics (ITRMF) posted quarterly Times Interest Earned of -$0.66 for Q3 2025, up 89.83% year-over-year from -$0.35 in Q3 2024, and down 43.97% quarter-over-quarter from -$0.46 in Q2 2025.

Iterum Therapeutics plc (ITRMF) Times Interest Earned (2017 - 2025) Analysis & Trends

Iterum Therapeutics' Times Interest Earned history runs 9 years deep, the most recent figure standing at -$0.66 for Q3 2025.

  • In Q3 2025, Times Interest Earned rose 89.83% year-over-year to -$0.66; the TTM figure through Sep 2025 stood at -$1.75 (up 85.05% YoY), while the FY2024 annual figure was -$0.42, up 63.16% from the prior year.
  • Times Interest Earned for Q3 2025 stood at -$0.66, down from -$0.46 in the prior quarter.
  • The five-year high for Times Interest Earned was -$0.46 in Q2 2025, with the low at -$124.16 in Q4 2021.
  • The 5-year median for Times Interest Earned is -$2.44 (2023), against an average of -$12.75.
  • The sharpest annual moves came in 2021 and 2022: Times Interest Earned slumped 26139.04% in 2021, then surged 97.71% in 2022.
  • Iterum Therapeutics' Times Interest Earned stood at -$124.16 in 2021, then soared by 98.97% to -$1.28 in 2022, then tumbled by 259.13% to -$4.61 in 2023, then surged by 71.22% to -$1.33 in 2024, then surged by 50.42% to -$0.66 in 2025.
  • Business Quant data shows ITRMF's Times Interest Earned at -$0.66 in Q3 2025, -$0.46 in Q2 2025, and -$5.41 in Q1 2025.

Peer Comparison

Historic Data

Download Data
DateValue
Sep 30, 2025 -0.66
Jun 30, 2025 -0.46
Mar 31, 2025 -5.41
Dec 31, 2024 -1.33
Sep 30, 2024 -6.46
Jun 30, 2024 -5.30
Mar 31, 2024 -8.23
Dec 31, 2023 -4.61
Sep 30, 2023 -5.31
Jun 30, 2023 -2.90
Mar 31, 2023 -1.98
Sep 30, 2022 -1.28
Jun 30, 2022 -1.32
Mar 31, 2022 -1.11
Dec 31, 2021 -124.16
Sep 30, 2021 -0.62
Jun 30, 2021 -57.74
Mar 31, 2021 -0.63
Dec 31, 2020 -20.28
Sep 30, 2020 -0.17